FREDUN PHARMACEUTICALS
|
|
BOM : 539730     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : NA |
May 25,2022 |
Price(EOD): ₹ 851.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 374.48 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
FREDUN PHARMACEUTICALS | -12.4% | -31% | 103% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 1.3% | 31.9% |
DIVIS LABORATORIES | -16.2% | -20.1% | -9.3% |
DR REDDYS LABORATORIES | 9.6% | 4.7% | -16.9% |
CIPLA | 3.6% | 1.9% | 4.7% |
GLAND PHARMA | -11.4% | -16.5% | -9.6% |
PIRAMAL ENTERPRISES | -4.4% | -14.3% | 4.7% |
CADILA HEALTHCARE | 8.2% | 7.4% | -39.9% |
TORRENT PHARMACEUTICALS | 1.7% | -3.5% | -4.6% |
FUNDAMENTAL ANALYSIS OF FREDUN PHARMACEUTICALS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF FREDUN PHARMACEUTICALS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
168.53
P/E Calculated based on EPS of 5.05
[ Mar2021 - Standalone Results ] 7.88
P/B Calculated based on Book Value of 107.96
[ Mar2021 - Standalone Results ] 1.66
P/S Calculated based on Revenues of 226.089 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
297% 151% 230% |
SHARE PRICE MOMENTUM OF FREDUN PHARMACEUTICALS
FREDUN PHARMACEUTICALS vs SENSEX
DEBT OF FREDUN PHARMACEUTICALS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.92 0.84 0.49 0.75 |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF FREDUN PHARMACEUTICALS
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF FREDUN PHARMACEUTICALS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
32.47% 23.9% 20.94% 22.65% |
69.53% 91.55% 206.55% 215.39% |
QtrlyTrend |
8 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
FREDUN PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about FREDUN PHARMACEUTICALS
Is FREDUN PHARMACEUTICALS good for long term investment?
As on May 25,2022, the Fundamentals of FREDUN PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of FREDUN PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is FREDUN PHARMACEUTICALS UnderValued or OverValued?
As on May 25,2022, FREDUN PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of FREDUN PHARMACEUTICALS ?
As on May 25,2022, the Intrinsic Value of FREDUN PHARMACEUTICALS is Rs. 257.78 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 214.31
Fair Value [Median EV / Sales Model] : Rs. 339.54
Fair Value [Median Price / Sales Model] : Rs. 257.78
Median Fair Value of FREDUN PHARMACEUTICALS : Rs. 257.78
Is FREDUN PHARMACEUTICALS trading at a Premium or Discount?
As on May 25,2022, FREDUN PHARMACEUTICALS is trading at a Premium of 230% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
